BioSpace News Archive

New Orleans Startup RDnote Wins Statewide BioChallenge Business Competition

The New Orleans BioInnovation Center announces that RDnote has won the 2017 BioChallenge pitch competition, an annual business challenge for Louisiana life science startups.

November 10, 2017
·
2 min read
Business

AveXis Reports Third Quarter 2017 Financial and Operating Results

As of September 30, 2017, AveXis had $374.2 million in cash and cash equivalents.

November 10, 2017
·
13 min read
Business

Bio-Path Holdings Reports Third Quarter 2017 Financial Results

The Company reported a net loss attributable to common stockholders of $2.5 million, or $0.02 per share, for the three months ended September 30, 2017.

November 10, 2017
·
6 min read
Business

CareDx Reports Third Quarter 2017 Financial Results

Achieved total revenue for the third quarter of 2017 of $12.2 million.

November 10, 2017
·
13 min read
Business

Dova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results

Dova reported a net loss of $9.7 million for the third quarter of 2017, compared to a net loss of $7.2 million for the same period in 2016.

November 10, 2017
·
6 min read
Business

Neovasc Inc. to Host Third Quarter 2017 Conference Call

The Company will subsequently hold a conference call that same day at 4:30 pm Eastern Time hosted by Mr. Alexei Marko, CEO, and Mr. Chris Clark, CFO.

November 10, 2017
·
1 min read
Policy

Vanda Receives Negative Opinion for Marketing Authorization From the European Medicines Agency on Fanaptum for the Treatment of Schizophrenia

After considering the grounds for this request, the CHMP re-examined the opinion and confirmed the refusal of the Fanaptum MAA on November 9, 2017.

November 10, 2017
·
1 min read
Business

KemPharm Reports Third Quarter 2017 Results and Provides Corporate Update

Net loss of $0.68 per basic and diluted share for the quarter ended September 30, 2017.

November 10, 2017
·
13 min read
Pharm Country

BOC Sciences Newly Broadens its Custom Synthesis Service Range

On October 16, 2017, BOC Sciences pronounced to broaden its custom synthesis service range which already exists.

November 10, 2017
·
1 min read
Pharm Country

Mylan Announces Voluntary Delisting From the Tel Aviv Stock Exchange (TASE)

Under Israeli law, the delisting of Mylan’s ordinary shares from the TASE will become effective in three months, on Feb. 12, 2018.

November 10, 2017
·
2 min read